Hughes and Associates

Hughes and Associates Hughes and Associates is your comprehensive executive and technical search firm.

We specialize in executive and technical recruitment exclusively for the pharmaceutical and biotechnology sectors, offering deep industry knowledge, a vast talent network, and an unwavering commitment to integrity and results. Whether your needs are finding a highly specialized candidate or enhancing your career, we are prepared to accept and complete your most challenging assignments. With our years of experience, knowledge, and extensive global network we will fulfill your every need efficiently and responsibly. We specialize in placing and recruiting applicants for positions in or related to: Mass Spectrometry, Drug Metabolism, Pharmacokinetics & Pharmacodynamics, Biostatistics, and ADME ; also known as Absorption, Distribution, Metabolism, and Excretion. Areas of Specialization
Research and Development Scientists: Analytical Chemists, Bioanalytical Chemists, Drug Metabolism Scientists, Formulation Scientists, Modeling and Simulation Specialists, and Pharmacokineticists

Pharmaceutical
Biotechnology Formulations
Contract Research Organizations
Generic Pharmaceuticals and OTC
Regulatory Affairs and Clinical Affairs

Pharmaceutical
Biotechnology
Contract Research Organizations
Management and Executives in the areas of Pharmaceutical, Biotechnology, and Contract Research Organizations

Research & Development
Quality Management
Clinical Research Management

To keep up with the latest job openings and industry news follow Hughes and Associates on all social media sites! https://twitter.com/jaychapman4
https://plus.google.com/+Haallc/posts
https://www.linkedin.com/company/hughes-and-associates

12/04/2025

🎙️ New Podcast Alert!
Give this a listen and stay ahead of the evolving 2025–2026 talent landscape in Modeling & Simulation.

Demand for QSP, Pharmacometrics, DMPK, PBPK, and Clinical Pharmacology talent is outpacing supply. As 2026 approaches, hybrid scientists and strong communicators will be among the most sought-after profiles in biopharma.

🔥 Key takeaways:
• Hybrid M&S scientists are becoming the gold standard
• Demand will continue to outpace supply in 2026
• Communication and cross-functional influence matter more than ever
• Market shifts are creating new mobility and career advantages

If you’re planning your next move or exploring the 2026 landscape, we can help you navigate the opportunities ahead.

👉 Ready to take the next step? Contact us directly at www.haallc.com

Model-informed drug development is evolving fast, and for QSP, Pharmacometrics, DMPK, PBPK, and Clinical Pharmacology pr...
12/02/2025

Model-informed drug development is evolving fast, and for QSP, Pharmacometrics, DMPK, PBPK, and Clinical Pharmacology professionals, 2026 will be a pivotal year.

The industry is moving toward hybrid scientists who can bridge computation, biology, and strategic decision-making. With the demand accelerating faster than the talent pool, top modeling & simulation experts are entering 2026 with unprecedented leverage.

Our latest newsletter highlights:
✅ Why hybrid profiles are becoming the new standard
✅ How demand for M&S talent will outpace supply even further in 2026
✅ The rising importance of communication and cross-functional impact
✅ New mobility created by retention challenges
✅ How to position your CV and career direction now for 2025–2026

👉 If you're exploring new opportunities or simply assessing your market position, this is the moment to prepare.

At Hughes & Associates, we support professionals across biotech and pharma, helping them translate scientific impact into strategic career growth.

🔗 Read the full feature and plan your 2025–2026 career strategy: https://www.haallc.com/2025/11/27/career-opportunities-in-2025-2026-positioning-yourself-for-model-informed-roles/

Uncover the trends in Model-Informed Drug Development and the growing demand for modeling and simulation experts in biopharma.

AI is accelerating change across life sciences in 2025, from personalized dosing to real-time modeling, advanced ADME pr...
11/19/2025

AI is accelerating change across life sciences in 2025, from personalized dosing to real-time modeling, advanced ADME predictions, and faster biomarker validation. These innovations are reshaping Clinical Pharmacology, Pharmacometrics, DMPK, QSP, and Bioanalysis, and driving demand for specialists who can integrate AI into scientific decision-making.

At Hughes and Associates, we help organizations find the cross-disciplinary experts who can bridge domain knowledge with AI-driven modeling and analysis.

💬Which AI-related skill is hardest for your team to hire for today?

11/14/2025

🎙️ New Podcast Episode: Hiring Challenges & Opportunities in 2025
Model-informed talent is reshaping drug development, and the competition for experts has never been sharper. From QSP to Pharmacometrics, Clinical Pharmacology, and DMPK, organizations are racing to secure the scientists who drive smarter decisions and stronger R&D outcomes.

🎧 Listen in: We break down the rise of hybrid scientists, why demand is outpacing supply, and what companies must do to build model-informed teams that can lead in 2025.

📺 Watch the full episode on YouTube and subscribe for more insights in quantitative drug development: https://lnkd.in/gCKiudg4

Thinking about strengthening your team or exploring new opportunities?
Schedule a complimentary call with our SVP, Jay Chapman
jchapman@haallc.com📞 704-264-5203

The race for drug development talent is accelerating. Are you keeping pace?In 2025, breakthroughs in biologics, gene the...
11/12/2025

The race for drug development talent is accelerating. Are you keeping pace?

In 2025, breakthroughs in biologics, gene therapies, mRNA vaccines, and rare disease research are transforming biopharma. But one reality remains:

💡 Science is advancing faster than the talent market.

Biotech and pharma companies are competing for a small pool of experts in QSP, Pharmacometrics, DMPK, and Clinical Pharmacology, professionals who not only model data but shape strategy and regulatory success.

Our latest newsletter explores:
✅ The rise of hybrid scientists bridging biology and computation
✅ How demand for modeling talent is outpacing supply
✅ The growing importance of collaboration and retention
✅ Why model-informed hiring is now a strategic imperative

👉 If your 2025 R&D goals depend on modeling and simulation, now is the time to act.
Traditional recruiting won’t secure the expertise you need, precision hiring will.

At Hughes & Associates, we specialize exclusively in building model-informed teams across biotech and pharma.
From Clinical Pharmacology to QSP, Pharmacometrics, and DMPK, we deliver the scientists who turn data into decisions.

Let’s build your next competitive advantage.
Contact Jay Chapman:
📧jchapman@haallc.com
📞704-264-5203

🔗 Read the full feature and discover how strategic recruitment drives innovation: https://hubs.ly/Q03SBVKt0

Explore how drug development is shaping the biopharma landscape in 2025, highlighting the need for specialized talent.

Behind every successful IND or NDA is a clinical pharmacology team making critical dose, safety, and modeling decisions ...
11/05/2025

Behind every successful IND or NDA is a clinical pharmacology team making critical dose, safety, and modeling decisions that define success.

💡Did you know:
• Up to 50% of a drug’s label is clinical pharmacology data.
• The FDA’s Model-Informed Drug Development (MIDD) approach is reshaping early development.
• The right clinical pharmacologist can de-risk millions in R&D investment.

At Hughes and Associates, we help life-science firms hire leaders who combine scientific rigor with strategic vision.

💬 What’s your biggest challenge in finding or retaining top clinical pharmacology talent?

Let’s talk strategy.
📩 jchapman@haallc.com
📞704-264-5203

10/24/2025

The Demand for DMPK Scientists: 2025 Career Insights

DMPK experts are shaping the future of drug development, and companies are hiring. We cover why demand is rising, where opportunities are growing, and how to take your next step.

Watch the full episode on YouTube and follow our page for new roles & tips: https://youtu.be/DV50QJgOY0Q

Want to discuss your next move?

Get in touch:
📩 https://www.haallc.com/contact-us/

We’re proud of our SVP, Jay Chapman, for representing Hughes and Associates as a panelist at the recent American Society...
10/23/2025

We’re proud of our SVP, Jay Chapman, for representing Hughes and Associates as a panelist at the recent American Society for Clinical Pharmacology & Therapeutics - ASCPT Career Connect event. 👏

The session, “Navigating the Evolving Landscape of Clinical Pharmacology: Strategies for Leadership, Innovation, and Impact in Drug Development”, brought together thought leaders to share forward-looking perspectives on innovation, leadership, and the future of drug development.

It’s inspiring to see such meaningful discussions shaping the next generation of scientific and strategic leadership within clinical pharmacology.

We look forward to continuing the conversation on advancing talent, innovation, and leadership across the life sciences.

Ready to elevate your career in clinical pharmacology? Join our expert-led webinar on leadership, innovation, and impact in drug development - Thursday, October 23 at 12 pm ET. Register today: https://bit.ly/4onMPaK

DMPK careers are heating up for 2025.Biotech and pharma are competing hard for DMPK talent, offering strong compensation...
10/21/2025

DMPK careers are heating up for 2025.
Biotech and pharma are competing hard for DMPK talent, offering strong compensation, hybrid flexibility, and clear growth paths.

In our new guide, we cover:
✅ Why DMPK skills are in demand
✅ What sets candidates apart
✅ Where the roles are
✅ How to stand out

➡️ Read the full article: https://www.haallc.com/2025/10/21/dmpk/

If you’re exploring your next move, partner with Hughes & Associates for access to unadvertised roles and strategic guidance tailored to your experience.

🤝 Connect with our team or reach out to Jay Chapman
📞 704-264-5203 | ✉️ jchapman@haallc.com

Explore the significance of DMPK in drug development and learn why DMPK skills are in high demand for professionals.

DMPK is at the heart of modern drug development and demand for experienced DMPK scientists is surging in 2025. In our la...
10/07/2025

DMPK is at the heart of modern drug development and demand for experienced DMPK scientists is surging in 2025.

In our latest article, we cover:
✅ Why DMPK demand keeps rising
✅ The most sought-after skills
✅ U.S. hiring hotspots
✅ Today’s hiring challenges and how to overcome them
✅ A quick DMPK Hiring Checklist for 2025 to guide your next search

If you’re building or scaling DMPK teams, these insights will help you compete and win.

👉Read the full article: https://www.haallc.com/blog/

Need help hiring? Schedule a complimentary consult with Hughes & Associates.
📞 704.333.5521 | ✉️ jchapman@haallc.com

Address

Charlotte, NC

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+17043335211

Alerts

Be the first to know and let us send you an email when Hughes and Associates posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

About Us

Hughes and Associates is your comprehensive executive and technical search firm servicing the pharmaceutical and biotechnology industries. Whether your needs are finding a highly specialized candidate or enhancing your career, we are prepared to accept and complete your most challenging assignments.


  • Experts with an extensive, continually expanding global network exclusively in the Biotechnology/Pharmaceutical industry.

  • Highly experienced and knowledgeable professionals who are best suited to achieve even the most difficult career goals.

  • A relationship-based firm dedicated to current and future recruitment needs.